Cytosorbents (CTSO) Misses Q1 EPS by 7c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss
• AXIL Brands (AXIL) Tops Q4 EPS by 4c